UBS raised the firm’s price target on Scotts Miracle-Gro (SMG) to $66 from $61 and keeps a Neutral rating on the shares. The operating environment and market backdrop for Consumer Staples remains challenging, but fundamentals could improve in 2026, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SMG:
- Scotts Miracle-Gro expects to combine Hawthorne with cannabis company
- Scotts Miracle-Gro CEO expresses support for cannabis rescheduling order
- Scotts Miracle-Gro: Strong Buy Recommendation Based on Promising Growth Projections and Valuation Upside
- Scotts Miracle-Gro Faces Financial Uncertainty Amid U.S. Legislative Challenges
- Scotts Miracle-Gro, Columbus Crew expand long-standing partnership